People Finance News, March 23 - Lingrei Pharmaceutical (600285) announced on March 23 that the company recently received the "Drug Registration Certificate" for aluminum magnesium carbonate chewable tablets approved and issued by the National Medical Products Administration. Aluminum magnesium carbonate chewable tablets are antacid and gastric mucosal protective non-prescription drugs. According to national relevant policies, this aluminum magnesium carbonate chewable tablets was approved for production as a Category 4 chemical drug, deemed to have passed the consistency evaluation of generic drug quality and efficacy, and is expected to have a positive impact on the company's operations.